Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Int J Environ Res Public Health ; 18(7)2021 03 30.
Article in English | MEDLINE | ID: covidwho-1377563

ABSTRACT

Vaccination is one of the most useful preventive interventions in healthcare. The purpose of our study was to gain overview of the opinions, knowledge, and engagement in vaccination practices among medical students (MS) and junior doctors (JD) in Europe. The survey was distributed from March 2016 until August 2016 via the e-mail and social media of the European Medical Students' Association. In total, 1821 responses from MS and JD from 34 countries in the European region were analysed. The majority of respondents agreed that vaccines are useful (98.7%) and effective (97.2%). Although the necessity of revaccination was supported by 99.2%, only 68.0% of the respondents went through with it. Even though the potential benefit of the flu vaccination seems to be acknowledged by our participants, only 22.1% of MS and JD declared getting the flu shot every or every other season. MS and JD were in favour of specific mandatory vaccination for medical staff (86.0%) and medical students (82.7%). Furthermore, we analysed the self-reported vaccination coverage of our participants regarding 19 vaccines. Of the respondents, 89.5% claimed to provide advice about vaccination to their friends and family. In conclusion, European MS and JD have a very positive attitude towards vaccination. However, their behaviour and knowledge demonstrate certain gaps which should be further addressed in medical education.


Subject(s)
Influenza Vaccines , Influenza, Human , Students, Medical , Cross-Sectional Studies , Europe , Health Knowledge, Attitudes, Practice , Humans , Self Report , Surveys and Questionnaires , Vaccination , Vaccination Coverage
2.
Pol Arch Intern Med ; 130(7-8): 615-621, 2020 08 27.
Article in English | MEDLINE | ID: covidwho-761203

ABSTRACT

INTRODUCTION: Coronavirus disease 2019 (COVID­19) is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2. OBJECTIVES: Our aim was to present an epidemiological analysis of the first 2 months (March and April 2020) of the COVID­19 epidemic in Poland. PATIENTS AND METHODS: This analysis was based on data from epidemiological reports collected between March 4 and April 30, 2020, by the Chief Sanitary Inspectorate. These epidemiological reports include data on sociodemographic characteristics of new laboratory­confirmed COVID 19 cases, the number of COVID­19-related deaths, the number of recovered COVID-19 patients as well as the number of laboratory tests performed. RESULTS: From March 4 to April 30, 2020, a total of 12 877 laboratory­confirmed COVID 19 cases were registered in Poland (55.7% women; mean [SD] age, 50.6 [20.5] years). The RT­ PCR test was performed in 338 000 patients. The notification rate for COVID­19 was 33.2 per 100 000 inhabitants. One third of laboratory­confirmed COVID 19 cases were among quarantined persons, 26.1% were related to the healthcare system (hospital or clinic), and 13.3% occurred in nursing homes. As of April 30, 2020, 644 COVID­19-related deaths were registered in Poland (46.5% women). The death rate for the whole country was 1.7 per 100 000 inhabitants. CONCLUSIONS: Our data showed higher notification rate for COVID­19 among women than men, but men were more likely to die from COVID­19. The notification rate for COVID-19 in Poland among women aged 45 to 54 years was 2­fold higher than among men.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Adolescent , Adult , Age Distribution , Aged , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Female , Health Services Accessibility/statistics & numerical data , Humans , Male , Middle Aged , Pandemics , Poland/epidemiology , Real-Time Polymerase Chain Reaction , SARS-CoV-2 , Sex Distribution , Young Adult
3.
Pol Arch Intern Med ; 130(6): 501-505, 2020 06 25.
Article in English | MEDLINE | ID: covidwho-618056

ABSTRACT

INTRODUCTION: The coronavirus disease 2019 (COVID 19) is a communicable disease caused by a novel coronavirus. OBJECTIVES: This study aimed to assess self­reported frequency of gastrointestinal symptoms and olfactory or taste disorders in nonhospitalized patients with COVID­19 in Poland. PATIENTS AND METHODS: This cross­sectional survey was conducted between April 17 and 18, 2020, in 4516 nonhospitalized patients with COVID­19 in Poland. The questionnaire included 8 questions related to the health status, symptoms of COVID­19, comorbidities, and smoking status. RESULTS: Completed questionnaires were obtained from 1942 patients with COVID­19 with a response rate of 43%. The median age of the respondents was 50 years; 60.2% were women. Among nonhospitalized patients with COVID­19, 21.3% had hypertension, 4.5% had diabetes, and 3.1% had a chronic respiratory disease. Regular tobacco use was declared by 11.2% of patients with COVID­19. At least one gastrointestinal symptom was reported by 53.6% of patients. Almost half of patients (47%) with COVID­19 reported lack of appetite and 24.2% reported diarrhea. Among 1942 interviewed patients, 54.2% reported at least 1 olfactory or taste disorder and 42.5% reported both alterations. Self­reported olfactory and taste disorders were 49.2% and 47.5%, respectively. Self­reported frequency of gastrointestinal symptoms and olfactory or taste disorders during COVID­19 was significantly higher (P <0.001) in women than men. CONCLUSIONS: This study demonstrated that olfactory and taste disorders are frequent symptoms in patients with mild­to­moderate COVID­19. Moreover, our study indicated sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among nonhospitalized patients with COVID­19.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Gastrointestinal Diseases/epidemiology , Pneumonia, Viral/epidemiology , Taste Disorders/epidemiology , Adult , COVID-19 , Comorbidity , Coronavirus Infections/diagnosis , Cross-Sectional Studies , Digestive System/virology , Female , Gastrointestinal Diseases/diagnosis , Humans , Male , Middle Aged , Pandemics , Pneumonia, Viral/diagnosis , Poland , SARS-CoV-2 , Surveys and Questionnaires , Taste Disorders/diagnosis
4.
Med Sci Monit ; 26: e924730, 2020 Apr 13.
Article in English | MEDLINE | ID: covidwho-52544

ABSTRACT

This study aimed (1) to present public health interventions to mitigate the early spread of SARS-CoV-2 implemented in Poland between January 9 and March 29, 2020, and (2) to analyze the potential impact of these regulations on the early phase of the COVID-19 outbreak in Poland. All legal regulations published in the Journal of Laws between January 9 and March 29, 2020, were analyzed. Out of 406 legal regulations identified, 56 were related to the COVID-19 outbreak. Moreover, the official announcements published on the governmental websites dedicated to the coronavirus and health issues were analyzed. On March 4, Poland reported the first laboratory-confirmed COVID-19 case. On March 9, Poland introduced border sanitary control. Six days after the first laboratory-confirmed COVID-19 case, all mass events in Poland were banned. All schools and universities were closed 8 days after the first COVID-19 case. All gastronomic facilities and sport and entertainment services were limited starting on March 14. Eleven days after the first COVID-19 case, controls at all Polish borders were introduced, and a ban on entry into Poland by foreigners (with some exemptions) was implemented. Starting on March 15, all citizens returning from abroad had to undergo compulsory 14 days self-quarantine. On March 20, a state of epidemic was announced, which resulted in new social distancing measures starting on March 25. In Poland, compared to other European countries, far-reaching solutions were implemented relatively early to reduce the spread of infection.


Subject(s)
Communicable Disease Control/methods , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Emergencies/epidemiology , Epidemics/prevention & control , Humans , Pneumonia, Viral/epidemiology , Poland/epidemiology , Quarantine , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL